Sen­a­tors call for hear­ing to ex­am­ine how Medicare will han­dle Bio­gen's new Alzheimer's drug

Two top Sen­ate Fi­nance com­mit­tee sen­a­tors on Thurs­day called for a hear­ing to ex­am­ine the ques­tions and chal­lenges for Medicare aris­ing from the FDA’s re­cent …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER